Concepedia

Publication | Open Access

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

DOIFull Paper Access

285

Citations

27

References

2006

Year

Ming‐Lung Yu, CY Dai, Jee‐Fu Huang, Nan Hou, L.-P. Lee, Meng‐Hsuan Hsieh, C.-F. Chiu, Szu‐Chia Chen, Meng‐Hsuan Hsieh, Liping Wang,
Gut

Abstract

16 weeks and 24 weeks of peginterferon treatment with weight-based ribavirin at a dose of 1000-1200 mg/day provided equal efficacy in patients with HCV2 who achieved RVR at 4 weeks.

References

YearCitations

Page 1